Investor Relations

Financial Releases

Date Title and Summary Additional Formats
Toggle Summary Intersect ENT to Present at the William Blair & Company 35th Annual Growth Stock Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that management will present an overview of the company's business at the William Blair & Company 35 th
View HTML
Toggle Summary Intersect ENT Announces Upsizing and Pricing of Public Offering
Public Offering of 3,582,000 Shares of Common Stock at $25.00 per Share, Resulting in Aggregate Proceeds of Approximately $89.6 Million MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and
View HTML
Toggle Summary Intersect ENT Commences Public Offering
Public Offering of 3,000,000 Shares of Common Stock MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the commencement of an underwritten public offering
View HTML
Toggle Summary Intersect ENT Files S-1 Registration Statement for Proposed Public Offering
Proposed Public Offering of 3,000,000 Shares of Common Stock MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today filed a registration statement on Form S-1 with the
View HTML
Toggle Summary Intersect ENT Reports First Quarter 2015 Results
Revenue Increased 78% Year Over Year to $13.4 Million MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March
View HTML
Toggle Summary Intersect ENT to Announce First Quarter Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release its first quarter financial results on May 6, 2015 .
View HTML
Toggle Summary Intersect ENT Reports Fourth Quarter and Year 2014 Results
Revenue Increased 115% Year Over Year to $38.6 Million MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the fourth quarter and year
View HTML
Toggle Summary Intersect ENT to Present at the 27th Annual ROTH Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the 27 th Annual ROTH Conference . The presentation is scheduled for 3:00 p.m. PT on Tuesday , March 10, 2015 , at the Ritz-Carlton in
View HTML
Toggle Summary Intersect ENT to Announce Fourth Quarter and Year 2014 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for the fourth quarter and year 2014 on February 26, 2015 .
View HTML
Toggle Summary Intersect ENT to Present at Leerink Partners Global Healthcare Conference 2015
MENLO PARK, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the Leerink Partners 2015 Global Healthcare Conference. The presentation is scheduled for 1:25 p.m.
View HTML